Cargando…
795. Review of Treatment of Latent Tuberculosis Infection at VA Portland Healthcare System
BACKGROUND: Treatment of latent tuberculosis infection (LTBI) is important for tuberculosis elimination in low-incidence countries. Currently, the VA Portland Health Care System (VAPORHCS) offers both 3HP (12-dose rifapentine plus isoniazid directly observed therapy (DOT)) and 9H (9-month daily ison...
Autores principales: | Xu, Teena, Forrest, Graeme N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253323/ http://dx.doi.org/10.1093/ofid/ofy210.802 |
Ejemplares similares
-
795. Impact of Revised Infectious Diseases Society of America and Society for Healthcare Epidemiology of America Guideline on the Classification of Clostridioides difficile Infection Severity
por: Carlson, Travis J, et al.
Publicado: (2020) -
2005. T-SPOT(®).TB Test for Latent Tuberculosis Infection Diagnosis and Treatment Guidance in Thai Healthcare Professionals
por: Khawcharoenporn, Thana, et al.
Publicado: (2018) -
796. Treatment of Latent Tuberculosis Infection in a Refugee Population
por: Herchline, Thomas, et al.
Publicado: (2018) -
938 Identification of High Risk Healthcare Workers with Latent Tuberculosis Infection (LTBI) in an Inner City Healthcare System
por: Dhar, Sorabh, et al.
Publicado: (2014) -
2194. Hepatitis B Care Cascade Within the VA Maryland Healthcare System
por: Lambing, Tyler, et al.
Publicado: (2018)